Clinical trial

Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)

NCT01289912

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-01-01

PhasePHASE2

Study timeline

Study start (unknown)2011-01-01Date precision: month

Registry last updated2018-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberous Sclerosis Complexunresolved

Interventions

RAD001DRUG

PlaceboDRUG

Sponsors & collaborators

Mustafa Sahinlead sponsor

Tuberous Sclerosis Alliancecollaborator

Autism Speakscollaborator

Novartis Pharmaceuticalscollaborator

Seizure Tracker LLCcollaborator

Mapped research locations

BostonMassachusetts, United States1 CincinnatiOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01289912 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.